<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03161743</url>
  </required_header>
  <id_info>
    <org_study_id>PRP Platelet Yield</org_study_id>
    <nct_id>NCT03161743</nct_id>
  </id_info>
  <brief_title>Calculation of Platelet-rich Plasma Preparation Yield</brief_title>
  <official_title>Calculation of Platelet-rich Plasma Preparation Yield From Baseline CBC Platelet Count</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Harrison, Theodore, M.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Harrison, Theodore, M.D.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a study to determine 1) the consistency of platelet-rich plasma produced by several
      methods, and 2) whether the platelet content of platelet-rich plasma can be accurately
      estimated from a baseline CBC platelet count.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the first phase of this study a baseline CBC platelet count will be performed on each
      subject and then platelet-rich plasma (PRP) prepared from the same blood sample by six
      different methods. The platelet count will be measured in each PRP preparation and compared
      to the CBC platelet count to determine the platelet yield for each method.

      In the second phase of the study a baseline CBC platelet count will be performed on each
      subject and then platelet-rich plasma (PRP) prepared from the same blood sample by six
      different methods. The CBC platelet count will be used to calculate the estimated platelet
      content of each sample/method based on the platelet yields determined in the first phase. The
      platelet count will be measured in each PRP preparation and compared to the estimated
      platelet content to determine the predictive accuracy for each method.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">June 30, 2017</start_date>
  <completion_date type="Anticipated">May 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Platelet yield</measure>
    <time_frame>within 8 hours of blood draw</time_frame>
    <description>the number of platelets in a PRP sample as a percentage of the number of platelets in the blood from which the PRP was prepared.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Platelet yield estimate accuracy</measure>
    <time_frame>within one month of final data collection</time_frame>
    <description>standard deviation of the difference between the estimated platelet yield and the actual platelet yield.</description>
  </primary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Platelet-rich Plasma Production</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>venipuncture</intervention_name>
    <description>blood draw for the purpose of determining the platelet concentration in PRP</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        normal adults
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  English speaking

        Exclusion Criteria:

          -  platelet count &lt; 150,000

          -  platelet count &gt; 350,000

          -  History of blood disorder

          -  History of altered platelet function

          -  History of chemotherapy or radiation therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Theodore E Harrison</last_name>
    <role>Principal Investigator</role>
    <affiliation>Theodore Harrison</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Theodore E Harrison</name>
      <address>
        <city>Sidney</city>
        <state>British Columbia</state>
        <zip>V8L5K1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 18, 2017</study_first_submitted>
  <study_first_submitted_qc>May 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 22, 2017</study_first_posted>
  <last_update_submitted>August 8, 2017</last_update_submitted>
  <last_update_submitted_qc>August 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Harrison, Theodore, M.D.</investigator_affiliation>
    <investigator_full_name>Theodore Harrison, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>platelet-rich plasma</keyword>
  <keyword>platelet</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

